Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Canavesi
Augusto Canavesi, Locate Varesino(co) IT
| Patent application number | Description | Published |
|---|---|---|
| 20100004449 | CRYSTALLINE FORMS OF ERLOTINIB BASE AND ERLOTINIB HCL - The preparation of crystalline Erlotinib base form G2 is described. This crystalline form can be converted to an Erlotinib salt, such as Erlotinib HCl, which can be used in the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). | 01-07-2010 |
Augusto Canavesi, Locate Varesino IT
| Patent application number | Description | Published |
|---|---|---|
| 20090124642 | Crystalline forms of Erlotinib HCI and formulations thereof - The invention provides a novel crystalline form of Erlotinib HCl, processes for its preparation, and formulations thereof. | 05-14-2009 |
| 20090131665 | Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI - The invention provides processes for preparing crystalline Forms A, B and pure crystalline Form A of Erlotinib hydrochloride. | 05-21-2009 |
| 20110118477 | SUNITINIB AND SALTS THEREOF AND THEIR POLYMORPHS - Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate. | 05-19-2011 |
Augusto Canavesi, Lacate Varesino (co) IT
| Patent application number | Description | Published |
|---|---|---|
| 20080214835 | Processes for preparing darifenacin hydrobromide - The invention encompasses processes for the preparation of darifenacin hydrobromide. | 09-04-2008 |
| 20090012295 | Amorphous Erlotinib, processes for the preparation thereof, and processes to prepare additional forms of Erlotinib - The present invention provides amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib. | 01-08-2009 |